Mon, November 9, 2020

Arlinda Lee Maintained (XFOR) at Strong Buy with Decreased Target to $20 on, Nov 9th, 2020

Arlinda Lee of Canaccord Genuity, Maintained "X4 Pharmaceuticals, Inc." (XFOR) at Strong Buy with Decreased Target from $22 to $20 on, Nov 9th, 2020.

Arlinda, nor any peers, have made any analyst calls on XFOR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30